DHR241101P272500
- 24.85
- -3.85-13.41%
Danaher Newsroom
Danaher Upgraded to Outperform by Wolfe, Recent Stock Drop Cited
Wolfe Research Upgrades Danaher(DHR.US) to Buy Rating, Announces Target Price $285
Danaher on Pace for Lowest Close Since July -- Data Talk
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $4,600 Today
Danaher (NYSE:DHR) Sheds 9.8% This Week, as Yearly Returns Fall More in Line With Earnings Growth
This week's U.S. stock market hot stocks | Stock prices surged! Tesla soared more than 20% after its performance, with a market cap skyrocketing by over $150 billion; excellent performance stock carnival week! The world's largest tobacco company, Philip M
This week, the dow jones industrial average fell by 2.08% to 42374.36 points; the s&p 500 index fell by 0.93% to 5809.86 points during the same period; the nasdaq index fell by 0.4% to 18415.49 points during the same period.
U.S. Companies Exposed to the Nuclear Energy Trend
Form 144 | Danaher(DHR.US) Insider Proposes to Sell 4.5 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Oct 23, $Danaher(DHR.US)$ Insider Weidemanis Joakim intends to sell 17,659 shares of its common stock on Oct 23, with a total market value of approximately $4.5 million.
Danaher Is Maintained at Overweight by Keybanc
Danaher Price Target Raised to $310.00/Share From $290.00 by Keybanc
UBS Adjusts Price Target on Danaher to $305 From $309, Maintains Buy Rating
Baird Maintains Outperform on Danaher, Lowers Price Target to $277
Danaher Analyst Ratings
Danaher (DHR) Gets a Hold From Barclays
Danaher Corp (DHR) Q3 2024 Earnings Call Highlights: Resilient Performance Amidst Market Challenges
Express News | Danaher Corp : Leerink Partners Cuts Target Price to $275 From $280
Decoding Danaher Corp (DHR): A Strategic SWOT Insight
Q3 2024 Danaher Corp Earnings Call
Danaher | 10-Q: Q3 2024 Earnings Report
Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating